Document is current
Any future updates will be listed below
-
Authors
Welz, Max
van der Aalst, Carlijn M.
Alfons, Andreas https://orcid.org/0000-0002-2513-3788
Naghi, Andrea A.
Heuvelmans, Marjolein A.
Groen, Harry J. M. https://orcid.org/0000-0002-2978-5265
de Jong, Pim A.
Aerts, Joachim https://orcid.org/0000-0001-6662-2951
Oudkerk, Matthijs https://orcid.org/0000-0003-2800-4110
de Koning, Harry J. https://orcid.org/0000-0003-4682-3646
ten Haaf, Kevin https://orcid.org/0000-0001-5006-6938
,
van der Aalst, Carlijn M.
Heuvelmans, Marjolein A.
Groen, Harry J. M.
de Jong, Pim A.
Aerts, Joachim
Oudkerk, Matthijs
de Koning, Harry J.
ten Haaf, Kevin
- License Information
-
More Information
Article History
Received: 3 October 2024
Accepted: 14 August 2025
First Online: 28 August 2025
Competing interests
: C.M.v.d.A. declares roles in the WHO-IARC European Code Against Cancer working group, B3care user committee and Expert Mission Cancer Screening in Georgia outside of the submitted work. H.J.G. declares consulting fees from Eli Lilly outside of the submitted work. P.A.d.J. research support from Philips Healthcare to their institute outside of the submitted work. J.A. declares speakers fees from Eli Lilly, MSD and BIOCAD, patents from Pamgene and Amphara, data safety monitoring/advisory board participation for Eli-Lilly, Amphara, BIOCAD and MSD, boardmembership of the IASLC and stock ownership in Amphera outside of the submitted work. H.J.d.K. declares consulting fees from Bayer and honoraria from TEVA/Menarini/Astra Zeneca outside of the submitted work. K.t.H. declares grants from NIH, Horizon 2020, University of Zurich, Cancer Research UK, Cancer Australia and the Australian Ministry of Health, speakers fees from Johnson&Johnson and Centre Hospitalier Universitaire Vaudois paid to their institute and travel support from the Rescue Lung Society outside of the submitted work. The remaining authors declare no competing interests.
